SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001072613-24-000471
Filing Date
2024-05-13
Accepted
2024-05-13 20:40:34
Documents
1
Group Members
ALI BEHBAHANIANTHONY A. FLORENCE, JR.CARMEN CHANGEDWARD T. MATHERSFOREST BASKETTMOHAMAD H. MAKHZOUMINEA 17 GP, LLCNEA PARTNERS 17, L.P.PAUL WALKERRICK YANGSCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 NEW ENTERPRISE ASSOCIATES 17, L.P. -- MONTE ROSA THERAPEUTICS 13D/A(#1) nea17-monterosa_18840.htm SC 13D/A 474796
  Complete submission text file 0001072613-24-000471.txt   476792
Mailing Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093
Business Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 410-842-4000
New Enterprise Associates 17, L.P. (Filed by) CIK: 0001768564 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118
Business Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118 617-949-2643
Monte Rosa Therapeutics, Inc. (Subject) CIK: 0001826457 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92649 | Film No.: 24941114
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)